Condition: Asthma
Interventions: Drug: Dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: asthma controller therapies (including prednisone/prednisolone)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified August 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days